Ozaki, Kei-Ichi <br/><br/>
Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes.  [electronic resource] 

 -  American journal of physiology. Endocrinology and metabolism  Apr 2016 
 - E643-E651 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1522-1555 
<br/><br/><label>Standard No.: </label>10.1152/ajpendo.00445.2015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3-L1 Cells<br/>Adipocytes--drug effects<br/>Adipokines--metabolism<br/>Adiponectin--metabolism<br/>Animals<br/>Benzamides--pharmacology<br/>Blood Glucose--drug effects<br/>Chemokine CCL2--drug effects<br/>Diabetes Mellitus, Type 2--metabolism<br/>Diet, High-Fat<br/>Diphenylamine--analogs & derivatives<br/>Disease Models, Animal<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Fatty Acids, Nonesterified--metabolism<br/>Glucose Tolerance Test<br/>Hyperlipidemias--metabolism<br/>Immunoblotting<br/>In Vitro Techniques<br/>Insulin--metabolism<br/>Insulin Resistance<br/>Interleukin-6--metabolism<br/>Lipolysis--drug effects<br/>MAP Kinase Signaling System--drug effects<br/>Male<br/>Mice<br/>Protein Kinase Inhibitors--pharmacology<br/>Real-Time Polymerase Chain Reaction<br/>Receptors, Leptin--deficiency<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction<br/>Triglycerides--metabolism<br/>Tumor Necrosis Factor-alpha--drug effects